Baiyunshan A: Production of anti-radiation drugs has no effect on performance

According to Baiyunshan A, the company's holding subsidiary, Guangzhou Baiyunshan Guanghua Company, is one of the major manufacturers of potassium iodide tablets for nuclear emergency use. At present, there are other domestic and international companies that produce similar products (potassium iodide for nuclear emergency).

According to reports, potassium iodide can prevent the accumulation of radioactive iodine in the thyroid gland and promote the accumulation of radioactive iodine in the gland to accelerate excretion. The special potassium iodide tablet for nuclear emergency contains 130 mg of potassium iodide (ie, 100 mg of pure iodine), which is used for the prevention of radioactive iodine required for off-site emergency of nuclear power plant accidents, and is not used as a common drug for treating other diseases. In 2010, Baiyunshan Guanghua Company's sales revenue for potassium iodide tablets for nuclear emergency was 251,800 yuan, accounting for 0.08% of the company's operating income.

According to Baiyunshan, in view of the special supply and specificity of potassium iodide, the company’s approval process for the production of potassium iodide tablets for nuclear emergency use is as follows: Each demand unit reports the demand plan to the province's nuclear emergency office, which will be purchased by the provincial nuclear emergency office. The plan is reported to the Guangdong Provincial Nuclear Emergency Office (such as the province's nuclear-free emergency office, which can report directly to the Guangdong Provincial Office of Nuclear Emergency Response). After the Guangdong Nuclear Emergency Response Office agrees, it is reported to the Guangdong Provincial Food and Drug Administration for review and approval. Baiyunshan Guanghua Company is based in Guangdong. Provincial Food and Drug Administration's relevant notice for production.

According to reports, Baiyunshan A holds 84.48% of the shares in Baihuashan Guanghua Co., Ltd. In addition to the production of potassium iodide tablets, the company is mainly engaged in the production and sales of chemical raw materials, preparations, and proprietary Chinese medicines. The main products include Xiaochaihu Granules and ammonia coffee yellows. Min capsules and so on. The company achieved operating income of 316 million yuan in 2010 and net profit of 11.11 million yuan.

In addition, Baiyun Mountain A expects that in the first three months of this year, net profit attributable to shareholders of listed companies will reach 66.38 million yuan to 99.56 million yuan, a year-on-year increase of 0% to 50%.